We previously reported that Cy given one day prior to a neu-targeted vaccine resulted in the partial depletion of Tregs, activation of endogenous high avidity RNEU420–429–specific CD8+ T cells, and tumor clearance in 20–30% of neu-N mice [11]. This evidence concerns the gene CD8A and neoplasm.